Paper17522860
Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
Butterfield LH and 3 others. Cancer Immunol Immunother, 2007. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Papers, record 17522860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522860
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Vaccines | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Immunotherapy | Major topic |
| Liver Neoplasms | Major topic |
| alpha-Fetoproteins | Major topic |
| Adult | |
| Aged | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Female | |
| Humans | |
| Leukocytes, Mononuclear | |
| Male | |
| Middle Aged | |
| Phenotype | |
| T-Lymphocytes |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA077623 | NCI NIH HHS | United States | R01CA077623 | PubMed and NIH | NIH RePORTER |
| R01 CA079976 | NCI NIH HHS | United States | R01CA079976 | PubMed and NIH | NIH RePORTER |
| R01 CA 79976 | NCI NIH HHS | United States | R01CA079976 | PubMed and NIH | NIH RePORTER |
| R01 CA 77623 | NCI NIH HHS | United States | R01CA077623 | PubMed and NIH | NIH RePORTER |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16177080 | Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis. | J Immunol | 2005 | https://conductscience.org/library/papers/16177080 | PubMed |
| 2 | 11300475 | Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11300475 | PubMed |
| 3 | 12907621 | Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. | Cancer Res | 2003 | https://conductscience.org/library/papers/12907621 | PubMed |
| 4 | 15838383 | Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. | J Immunother | 2005 | https://conductscience.org/library/papers/15838383 | PubMed |
| 5 | 10537110 | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. | Nature | 1999 | https://conductscience.org/library/papers/10537110 | PubMed |
| 6 | 15314544 | Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy. | J Immunother | 2004 | https://conductscience.org/library/papers/15314544 | PubMed |
| 7 | 12229971 | Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein. | Scand J Gastroenterol | 2002 | https://conductscience.org/library/papers/12229971 | PubMed |
| 8 | 16887960 | CCR5 in T cell-mediated liver diseases: what's going on? | J Immunol | 2006 | https://conductscience.org/library/papers/16887960 | PubMed |
| 9 | 10453947 | Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. | J Hepatol | 1999 | https://conductscience.org/library/papers/10453947 | PubMed |
| 10 | 7544570 | Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms. | Anticancer Res | 1995 | https://conductscience.org/library/papers/7544570 | PubMed |
| 11 | 16339586 | Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. | J Immunol | 2005 | https://conductscience.org/library/papers/16339586 | PubMed |
| 12 | 12631598 | Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12631598 | PubMed |
| 13 | 89800 | alpha-Fetoprotein in cancer and fetal development. | Adv Cancer Res | 1979 | https://conductscience.org/library/papers/89800 | PubMed |
| 14 | 16785572 | Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes. | J Immunol | 2006 | https://conductscience.org/library/papers/16785572 | PubMed |
| 15 | 11751399 | alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. | Cancer Res | 2001 | https://conductscience.org/library/papers/11751399 | PubMed |
| 16 | 16675576 | A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16675576 | PubMed |
| 17 | 16166448 | Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16166448 | PubMed |
| 18 | 12165275 | Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. | Clin Immunol | 2002 | https://conductscience.org/library/papers/12165275 | PubMed |
| 19 | 10554020 | Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. | Cancer Res | 1999 | https://conductscience.org/library/papers/10554020 | PubMed |
| 20 | 15297413 | Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15297413 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41403946 | LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort. | Front Immunol | 2025 | https://conductscience.org/library/papers/41403946 | PubMed |
| 41332779 | An Interpretable Multi-instance Learner Decodes Cellular Recruitment from Spatially Resolved Transcriptomics. | bioRxiv | 2025 | https://conductscience.org/library/papers/41332779 | PubMed |
| 39309303 | Dendritic Cell-Related Gene Signatures in Hepatocellular Carcinoma: An Analysis for Prognosis and Therapy Efficacy Evaluation. | J Hepatocell Carcinoma | 2024 | https://conductscience.org/library/papers/39309303 | PubMed |
| 38660138 | The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. | Front Oncol | 2024 | https://conductscience.org/library/papers/38660138 | PubMed |
| 38543304 | Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38543304 | PubMed |
| 38195534 | Evolution of cell therapy for renal cell carcinoma. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38195534 | PubMed |
| 36139542 | Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139542 | PubMed |
| 34764464 | Immunotherapies for hepatocellular carcinoma. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/34764464 | PubMed |
| 33841570 | Irradiated whole-cell vaccine suppresses hepatocellular carcinoma growth in mice via Th9 cells. | Oncol Lett | 2021 | https://conductscience.org/library/papers/33841570 | PubMed |
| 33801203 | CD8+ T Cell Responses during HCV Infection and HCC. | J Clin Med | 2021 | https://conductscience.org/library/papers/33801203 | PubMed |
| 32565925 | Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model. | Ther Adv Med Oncol | 2020 | https://conductscience.org/library/papers/32565925 | PubMed |
| 32164075 | [Research progress of alpha-fetoprotein vaccine in hepatocellular carcinoma]. | Zhonghua Gan Zang Bing Za Zhi | 2020 | https://conductscience.org/library/papers/32164075 | PubMed |
| 31497249 | Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma. | Oncotarget | 2019 | https://conductscience.org/library/papers/31497249 | PubMed |
| 31039795 | Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma. | Genome Med | 2019 | https://conductscience.org/library/papers/31039795 | PubMed |
| 29740200 | Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/29740200 | PubMed |
| 29296523 | Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29296523 | PubMed |
| 29119057 | Dendritic cells based immunotherapy. | Am J Cancer Res | 2017 | https://conductscience.org/library/papers/29119057 | PubMed |
| 29112462 | Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/29112462 | PubMed |
| 28123463 | Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28123463 | PubMed |
| 26755874 | Current status and perspectives of immune-based therapies for hepatocellular carcinoma. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26755874 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17522860
GET https://conductscience.org/api/papers/v1/17522860/references?page=2